Tirzepatide and the Dual Incretin Mechanism
Tirzepatide is an approved molecule that carries both incretin hormones in a single peptide, and the trial record that followed […]
Semaglutide: How the First Oral GLP-1 Changed Metabolic Medicine
The story of semaglutide is the story of a peptide that crossed the last barrier in drug delivery, and the
What the Evidence Says About Peptide Stacks for Weight Loss
The marketed peptide stacks for weight loss all run ahead of the evidence, so this article maps each compound to
What Happens When You Stop GLP-1 Therapy
The withdrawal trials and real-world cohorts now quantify what comes back when GLP-1 therapy stops, and the honest answer mixes
GHK-Cu is the iceberg peptide
GHK-Cu was discovered in 1973 by Dr. Loren Pickart, who found that a tripeptide in human plasma, glycine-histidine-lysine bound to
BPC-157 and TB-500: the wolverine stack, what the preclinical evidence shows, and what the human data does not yet tell us
<p class="standfirst">The combination of BPC-157 and TB-500 (thymosin beta-4) has acquired the nickname "the wolverine stack" in athletic and biohacking
CJC-1295 with DAC vs without DAC: what the difference actually means
CJC-1295 without DAC is a modified growth hormone releasing hormone analog that produces a brief, natural pulse of GH release,
MOTS-c: the mitochondrial peptide for metabolic health
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome’s 12S ribosomal RNA region, making it one of the few
GHK-Cu: copper peptide benefits and research
GHK-Cu is a naturally occurring tripeptide with high affinity for copper ions that was discovered in human plasma by Dr.
Retatrutide vs Semaglutide vs Tirzepatide
The GLP-1 landscape has evolved through three generations in less than a decade, and each generation represents a fundamentally different